Global Brain Monitoring Systems Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product Type (Electroencephalography (EEG), Magnetoencephalography (MEG), Magnetic Resonance Imaging (MRI), Cerebral Oximeters, Others), By Application (Traumatic Brain Injury (TBI), Epilepsy, Alzheimer’s Disease, Others), By End User (Hospitals & Clinics, Neurological Centers, Academic And Research Institutes) And By Geography - Forecasts From 2022 To 2027

Published:  Nov 2022 Report Code: KSI061612145 Pages: 111

The global brain monitoring systems market is projected to grow at a CAGR of 7.59% to reach US$3.350 billion by 2027, from US$2.008 billion in 2020.

In neurological testing, brain monitoring systems are used to identify any irregularity in the functionality of brain cells (neurons) that contributes to the development of neurological illnesses such as Parkinson's disease, epilepsy, Alzheimer's, and sleep problem. These technologies enable the monitoring and detection of neuronal activity without the need for invasive neurosurgery. Monitoring patients with traumatic brain injuries are becoming increasingly important to avoid further brain damage, especially cerebral ischemia. The rising need for evaluating elevated intracranial pressure (ICP) in monitoring patients will drive demand for brain monitoring devices. Additionally, according to the US National Institute of Mental Health (NIMH) 2020, one in every four American individuals has a diagnosable mental condition in any given year, with almost 6% having a severe disability. According to the same estimate, the overall annual cost of serious mental illness in the United States surpasses USD 317 billion. Therefore, this would also lead the market to grow during the projected period.

The brain monitoring market is relatively competitive, with both large and small industry participants. In terms of market share, a small number of significant firms now dominate the market analyzed in certain areas. However, with technology improvements and product breakthroughs, mid-size to smaller businesses have increased their market presence by bringing new, more usable technologies.

The primary drivers driving market expansion in the studied industry are aging demographics, increased prevalence of brain illnesses, and gadget simplicity of use and mobility.

In the United States, traumatic brain injury (TBI) is a leading cause of mortality and disability. TBIs account for around 30% of all injury mortality. Every day, 153 people in the United States die from injuries that include TBI (source: Centers for Disease Control and Prevention). In addition, rising healthcare expenditure and high incidences of neurological disorders due to changing living conditions and increasing stress levels are driving the market growth. Furthermore, the growing technological advancements will provide an opportunity for the development of brain sensors which will boost the growth of global brain monitoring devices in the forecast period. Moreover, the first versions of EEG monitors were filled with cables and electrodes, and even today, the great majority of devices are based on this traditional architecture. However, with the introduction of wireless connectivity, the size and awkwardness of EEG monitors and other associated equipment have been greatly decreased.

Rising Innovation in the market

The rising prevalence of various neurodegenerative and neurological disorders has led to an increased frequency of innovation in mobile EEG devices, real-time monitoring, and alarms which is thus attributing to the demand for brain monitoring products. According to the National Institute of Neurological Disorders and Stroke, about 30 million people in the US alone suffer from at least one of the nearly 7,000 identified uncommon or ultra-rare disorders. More than 45% of uncommon diseases are associated with neurological symptoms. Factors like this are thus expected to surge the demand for brain monitoring products thus driving the market. Furthermore, a rising number of regulatory approvals for brain health devices is projected to drive the growth of the global brain monitoring systems market. Several hospitals and healthcare organizations implement the insertion of brain implants in patients who are at risk of developing neurological disorders, to provide artificial control on brain functioning. Additionally, regulatory approvals for innovative and advanced brain health devices are predicted to propel the growth of the market in the near future. For instance, in April 2019, GE Healthcare received the US Food and Drug Administration 510(k) clearance for its Deep Learning Image Reconstruction engine on the new Revolution Apex computed tomography device.

Product Insights

  • Bispectral Index™ (BIS™) is a monitoring that enhances the clinician’s patient-targeted approach to induction, maintenance, and emergence. BIS™ technology non-invasively measures and interprets the wave activity of the brain directly related to the effects of anesthetic agents.
  • SedLine® Brain Function Monitoring is a brain monitoring system that helps clinicians monitor the state of the brain under anesthesia with bilateral data acquisition and processing of EEG signals that helps clinicians with anesthetic management. 

Market Key Developments

  • In March 2022, Axiom Space launched its Axiom-1 (Ax-1) objective to the International Space Station (ISS) aboard a SpaceX Dragon spacecraft. The helmet was created by the Israeli business brain. space and is based on the EEG technique, which monitors specific signals generated by the brain. The helmet, according to the corporation, will be worn by the Ax-1 astronauts to monitor and analyze their brain activity to investigate if findings acquired in microgravity differ from those acquired on Earth.
  • In April 2021, Integra LifeSciences Corporation received 510(k) approval from the US FDA for their revolutionary CereLink ICP Monitor. This device is designed to act as a bridge between normal physical pressure monitoring systems and appropriate stress pressure transducers.
  • In February 2020, Compumedics Limited acquired 510k approval from the US FDA for its Orion LifeSpan MEG, which is equipped to non-invasively assess magnetoencephalographic (MEG) signals as well as electroencephalographic (EEG) signals produced by electrically active brain tissue. DelveInsight anticipates fast development in the Brain Monitoring System market during the projected period due to the introduction of many products.

Global Brain Monitoring Systems Market Scope:


Report Metric Details
 Market Size Value in 2020  US$2.008 billion
 Market Size Value in 2027  US$3.350 billion
 Growth Rate  CAGR of 7.59% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments Covered  Product Type, Application, End User, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered Compumedics Limited, GENERAL ELECTRIC COMPANY, Medtronic, Natus Medical Incorporated, NIHON KOHDEN CORPORATION, Tristan Technologies, Inc., Masimo Corporation, Canon Medical Systems Corporation, CortiCare, Inc., NeuroWave Systems Inc.
 Customization Scope  Free report customization with purchase



  • By Product Type
    • Electroencephalography (EEG)
    • Magnetoencephalography (MEG)
    • Magnetic Resonance Imaging (MRI)
    • Cerebral Oximeters
    • Others
  • By Application
    • Traumatic Brain Injury (TBI)
    • Epilepsy
    • Alzheimer’s Disease
    • Others
  • By End User
    • Hospitals & Clinics
    • Neurological Centers
    • Academic and Research Institutes
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    •  Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the brain monitoring systems market size by 2027?
A1. The global brain monitoring systems market is projected to reach a market size of US$3.350 billion by 2027.

Q2. What is the size of the global brain monitoring systems market?
A2. Brain Monitoring Systems Market was valued at US$2.008 billion in 2020.

Q3. What are the growth prospects for the brain monitoring systems market?
A3. The brain monitoring systems market is projected to grow at a CAGR of 7.59% over the forecast period.

Q4. What factors are anticipated to drive the brain monitoring systems market growth?
A4. The primary drivers driving the brain monitoring systems market growth are aging demographics, increased prevalence of brain illnesses, and gadget simplicity of use and mobility.

Q5. Who are the major players in the global brain monitoring systems market?
A5. Major industry players profiled as part of the brain monitoring systems market report are Compumedics Limited, GENERAL ELECTRIC COMPANY, Medtronic, Natus Medical Incorporated, NIHON KOHDEN CORPORATION, and Tristan Technologies, Inc. among others.


1.1. Market Overview

1.2. COVID-19 Scenario

1.3. Market Definition

1.4. Market Segmentation



2.1. Research Data

2.2. Assumptions



3.1. Research Highlights



4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis



5.1. Introduction

5.2. Electroencephalography (EEG)

5.3. Magnetoencephalography (MEG)

5.4. Magnetic Resonance Imaging (MRI)

5.5. Cerebral Oximeters

5.6. Others



6.1. Introduction

6.2. Traumatic Brain Injury (TBI)

6.3. Epilepsy

6.4. Alzheimer’s Disease

6.5. Others



7.1. Introduction

7.2. Hospitals & Clinics

7.3. Neurological Centers

7.4. Academic and Research Institutes



8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. Japan

8.6.3. South Korea

8.6.4. India

8.6.5. Indonesia

8.6.6. Others



9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix



10.1. Compumedics Limited


10.3. Medtronic

10.4. Natus Medical Incorporated


10.6. Tristan Technologies, Inc.

10.7. Masimo Corporation

10.8. Canon Medical Systems Corporation

10.9. CortiCare, Inc.

10.10. NeuroWave Systems Inc.

Compumedics Limited



Natus Medical Incorporated


Tristan Technologies, Inc.

Masimo Corporation

Canon Medical Systems Corporation

CortiCare, Inc.

NeuroWave Systems Inc.


Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


We are in compliance with the global privacy laws.

Connect With Us